Nyxoah SA (NYXH) News
Filter NYXH News Items
NYXH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NYXH News Highlights
- NYXH's 30 day story count now stands at 2.
- Over the past 3 days, the trend for NYXH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SA, ACT and AHI are the most mentioned tickers in articles about NYXH.
Latest NYXH News From Around the Web
Below are the latest news stories about NYXOAH SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® Data presented at the DGSM Conference in Berlin by Dr. Christian Plettenberg on December 8, 2023Results showed an average AHI decrease of 73% Mont-Saint-Guibert, Belgium – December 11, 2023, 7:30am CET / 1:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to |
Publication Relating to a Transparency NotificationREGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On December 6, 2023, Nyxoah received a transparency notification from Deerfield Partners, L.P. indicating that Deerfield Partners, L.P. cr |
Nyxoah Strengthens its Executive Leadership TeamNyxoah Strengthens its Executive Leadership TeamFrancis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis Kim as Chief Regulatory and Quality Officer. Francis will |
Why Is AgriForce Growing Systems (AGRI) Stock Moving Today?AgriForce Growing Systems stock is on the move Monday as AGRI investors react to a letter from the company's CEO concerning its performance. |
Why Is Altamira Therapeutics (CYTO) Stock Down 8% Today?Altamira Therapeutics stock is sliding lower on Monday as investors in CYTO shares react to a delisting notice from the Nasdaq Exchange. |
Why Is Nyxoah (NYXH) Stock Up 4% Today?Nyxoah stock is climbing higher on Monday as investors in NYXH shares prepare for the company to host a fireside chat this week. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! |
Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes place November 2 |
Nyxoah S.A. (NASDAQ:NYXH) Q3 2023 Earnings Call TranscriptNyxoah S.A. (NASDAQ:NYXH) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good day and thank you for standing by. Welcome to the Nyxoah’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised […] |
Nyxoah Reports Third Quarter 2023 Financial and Operating ResultsNyxoah Reports Third Quarter 2023 Financial and Operating ResultsPartners with ResMed Germany to increase OSA awareness and therapy penetration Mont-Saint-Guibert, Belgium – November 8, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the third quarter |